Linezolid Krka (Linezolid)

Linezolid is an oxazolidinone antibacterial indicated for several serious Gram‑positive infections.

• Methicillin‑resistant Staphylococcus aureus (MRSA) infections: effective in treating skin, bloodstream and pulmonary infections caused by MRSA.
• Vancomycin‑resistant Enterococcus (VRE) infections: used to eradicate VRE in complicated intra‑abdominal and urinary tract infections.
• Community‑acquired pneumonia: provides coverage against typical and atypical pathogens, including resistant strains.
• Skin and soft‑tissue infections: resolves cellulitis, abscesses and wound infections caused by susceptible Gram‑positive bacteria.

• Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. This interaction prevents the formation of the initiation complex required for translation, thereby halting bacterial growth. The binding is reversible and selective for bacterial ribosomes, which accounts for its activity against Gram‑positive organisms, including strains resistant to other classes of antibiotics. By targeting a step not addressed by beta‑lactams or glycopeptides, linezolid offers a distinct mechanism useful in multidrug‑resistant infections.

Linezolid may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Nausea: mild stomach upset.
• Diarrhea: loose stools.
• Headache: transient cranial discomfort.

Serious or Rare Side Effects

• Thrombocytopenia: significant platelet count reduction.
• Peripheral neuropathy: nerve pain or tingling, may be irreversible.
• Serotonin syndrome: potentially life‑threatening reaction with serotonergic drugs.

When prescribing linezolid, several safety considerations should be observed to minimize risk.

• Monitor blood counts: check CBC regularly for thrombocytopenia or anemia.
• Assess renal and hepatic function: adjust therapy if severe impairment is present.
• Avoid serotonergic agents: concurrent use with SSRIs, MAOIs or tricyclics can trigger serotonin syndrome.
• Use caution in hypertensive patients: linezolid may potentiate pressor responses to tyramine‑rich foods.
• Evaluate for myelosuppression: discontinue if severe cytopenias develop.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Linezolid interacts with several drug classes; awareness of major and moderate interactions helps guide safe co‑administration.

Major Interactions (Avoid)

• Serotonergic antidepressants (SSRIs, SNRIs, MAO inhibitors): risk of serotonin syndrome.
• Sympathomimetic agents (pseudoephedrine, phenylephrine): may cause hypertensive crisis.
• Tyramine‑rich foods: can lead to elevated blood pressure due to MAO inhibition.

Moderate Interactions (Monitor Closely)

• Rifampin: induces hepatic enzymes, reducing linezolid plasma levels.
• Fluconazole: inhibits metabolism, potentially increasing linezolid exposure.
• Warfarin: may enhance anticoagulant effect, requiring INR monitoring.